| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 169 | 189 | −11.0% |
| EBITDA | 9.6 | 9.9 | −3.7% |
| EBITDA margin | 5.7% | 5.2% | +0.4 pts |
| Profit before tax | 3.1 | 4.6 | −32.8% |
| Net profit | 2.4 | 3.9 | −37.6% |
| EPS | ₹0.38 | ₹0.80 | −52.5% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 370 | — | — | |
| 12.3 | 12.3 | 9.7 | |
| 177 | 177 | 227 | |
| 535 | — | — | |
| 684 | 705 | 590 | |
| — | +19.3% | — | |
| 73.6 | 74.0 | 64.3 | |
| 10.8% | 10.5% | 10.9% | |
| 61.9 | 62.6 | 53.7 | |
| 38.6 | 40.0 | 31.5 | |
| 5.6% | 5.7% | 5.3% | |
| ₹6.10 | ₹6.33 | ₹4.98 | |
| — | +27.2% | — | |
| — | −40.7 | −14.8 | |
| — | −28.4 | −42.2 | |
| −69.1 | −69.1 | −56.9 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|
| Market Capitalization | — | — | 370.1 | |
| - Cash, Equiv & ST Investments | 9.7 | 12.3 | 12.3 | |
| + Total Debt | 226.7 | 176.9 | 176.9 | |
| Enterprise Value | — | — | 534.7 | |
| Revenue | 590.4 | 704.6 | 683.8 | |
| Growth %, YoY | — | +19.3 | — | |
| EBITDA | 64.3 | 74.0 | 73.6 | |
| Margin % | 10.89 | 10.50 | 10.77 | |
| EBIT | 53.7 | 62.6 | 61.9 | |
| Net Income | 31.5 | 40.0 | 38.6 | |
| Margin % | 5.33 | 5.68 | 5.64 | |
| EPS, Adj (current shares) | 4.98 | 6.33 | 6.10 | |
| Growth %, YoY | — | +27.2 | — | |
| Cash from Operations | -14.8 | -40.7 | — | |
| Capital Expenditures | -42.2 | -28.4 | — | |
| Free Cash Flow | -56.9 | -69.1 | -69.1 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Indogulf Cropsciences (NSE: IGCL) had a market capitalisation of ₹391 crore at the 30 October 2026 close (₹61.84 a share), a PE ratio of 10.1 on the last four quarters' profit and a price-to-book ratio of 0.85. In FY26 its consolidated net profit was ₹40 crore on revenue of ₹705 crore; in Q1 FY27 (April–June 2026) it was ₹2.4 crore, down 37.6% year on year. Its debt-to-equity ratio was 0.39 on 31 March 2026. Promoters held 69.05% of the shares on 30 September 2026.
Indogulf Cropsciences' PE ratio is 10.1 at the 30 October 2026 close (₹61.84 a share): a market capitalisation of ₹391 crore divided by consolidated net profit of ₹38.6 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹40 crore) it is 9.8.
Indogulf Cropsciences' price-to-book (PB) ratio is 0.85 at the 30 October 2026 close: a market capitalisation of ₹391 crore divided by shareholders' equity (book value) of ₹459 crore on 31 March 2026. That is a book value of ₹72.65 per share against a share price of ₹61.84.
Indogulf Cropsciences' debt-to-equity ratio was 0.39 on 31 March 2026: borrowings of ₹177 crore against total equity of ₹459 crore. A year earlier, on 31 March 2025, it was 0.82.
Indogulf Cropsciences' market capitalisation was ₹391 crore at the 30 October 2026 close: 6.32 crore shares at ₹61.84 each.
No. Indogulf Cropsciences had borrowings of ₹177 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.39. Its cash and current investments were ₹12.3 crore, so its net debt was ₹165 crore.
Indogulf Cropsciences' basic earnings per share (EPS) were ₹6.72 in FY26, against ₹7.02 in FY25.
Indogulf Cropsciences' net worth — shareholders' equity in its consolidated balance sheet — was ₹459 crore on 31 March 2026, up 66.9% from ₹275 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹391 crore at the 30 October 2026 close.
Indogulf Cropsciences' book value per share was ₹72.65 on 31 March 2026: shareholders' equity of ₹459 crore divided by the 6.32 crore shares in issue. The share price at the 30 October 2026 close was ₹61.84.
Promoters held 69.05% of Indogulf Cropsciences on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Indogulf Cropsciences' return on equity (ROE) was 10.9% and its return on capital employed (ROCE) was 15.7%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
On 30 September 2026, Indogulf Cropsciences' shares were held by promoters 69.05%, foreign portfolio investors (FII/FPI) 0.07%, domestic institutions (DII) 3.77% and retail and other non-institutional investors 27.11%. Over the year, FII holding was down 0.34 percentage points from 0.41% and DII holding was down 2.46 percentage points from 6.23%.
In FY26, Indogulf Cropsciences generated ₹40.7 crore of cash from operations and spent ₹28.4 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹69.1 crore. In FY25 it was −₹56.9 crore.
Indogulf Cropsciences' latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: consolidated net profit ₹2.4 crore, down 37.6% from ₹3.9 crore in Q1 FY26; revenue from operations ₹169 crore, down 11.0% year on year.
In FY26 (April 2025–March 2026), Indogulf Cropsciences' consolidated net profit was ₹40 crore, up 27.2% from ₹31.5 crore in FY25, on revenue from operations of ₹705 crore (up 19.3%).
Indogulf Cropsciences will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, the date of the board meeting it has notified to the exchanges.
On FY26 consolidated figures, against Best Agrolife, Heranba Industries and Advance Agrolife: Indogulf Cropsciences' operating margin of 8.9% is the highest of the four (Best Agrolife 4.7%, Heranba Industries −1.8%, Advance Agrolife 8.3%; peer average 3.7%); its return on equity of 10.9% is the second highest of the four (Best Agrolife 1.2%, Heranba Industries −9.5%, Advance Agrolife 11.4%; peer average 1.0%).
In FY26, Indogulf Cropsciences earned net profit of ₹40 crore on revenue of ₹705 crore, against ₹8.9 crore on ₹1,257 crore for Best Agrolife. Indogulf Cropsciences' operating margin was 8.9% (Best Agrolife 4.7%) and its return on equity 10.9% (Best Agrolife 1.2%). At the 30 October 2026 close, Indogulf Cropsciences' market capitalisation was ₹391 crore against ₹496 crore for Best Agrolife, and its PE ratio on FY26 profit 9.8 against 55.9.
From Indogulf Cropsciences' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.